273
Views
2
CrossRef citations to date
0
Altmetric
ONCOLOGY

Management of the neck in node-positive tonsillar cancer

, &
Pages 1094-1100 | Received 24 Feb 2014, Accepted 24 Apr 2014, Published online: 15 Sep 2014

References

  • Hammarstedt L, Dahlstrand H, Lindquist D, Onelov L, Ryott M, Luo J, et al. The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 2007;127:988–92.
  • Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009;125:362–6.
  • Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294–301.
  • Soltys SG, Choi CY, Fee WE, Pinto HA, Le QT. A planned neck dissection is not necessary in all patients with N2-3 head-and-neck cancer after sequential chemoradiotherapy. Int J Radiat Oncol Biol Phys 2012;83:994–9.
  • Hamoir M, Ferlito A, Schmitz S, Hanin FX, Thariat J, Weynand B, et al. The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease. Oral Oncol 2012;48:203–10.
  • Goguen LA, Posner MR, Tishler RB, Wirth LJ, Norris CM, Annino DJ, et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2006;132:526–31.
  • Stenson KM, Huo D, Blair E, Cohen EE, Argiris A, Haraf DJ, et al. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope 2006;116:33–6.
  • McHam SA, Adelstein DJ, Rybicki LA, Lavertu P, Esclamado RM, Wood BG, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003;25:791–8.
  • Cannady SB, Lee WT, Scharpf J, Lorenz RR, Wood BG, Strome M, et al. Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma. Head Neck 2010;32:348–56.
  • Brizel DM, Prosnitz RG, Hunter S, Fisher SR, Clough RL, Downey MA, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;58:1418–23.
  • Igidbashian L, Fortin B, Guertin L, Soulieres D, Coulombe G, Belair M, et al. Outcome with neck dissection after chemoradiation for N3 head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2010;77:414–20.
  • Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004;26:447–55.
  • Stenson KM, Haraf DJ, Pelzer H, Recant W, Kies MS, Weichselbaum RR, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000;126:950–6.
  • Ahlberg A, Lagerlund M, Lewin F, Friesland S, Lundgren J. Clinical outcome following radiotherapy and planned neck dissection in N+ head and neck cancer patients. Acta Otolaryngol 2008;128:1354–60.
  • Velazquez RA, McGuff HS, Sycamore D, Miller FR. The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2004;130:74–7.
  • Nayak JV, Walvekar RR, Andrade RS, Daamen N, Lai SY, Argiris A, et al. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope 2007;117:2129–34.
  • Kohlfurst S, Markitz M, Raunik W, Eckel HE, Kresnik E, Hausegger K, et al. [Positron-emission tomography (PET) and PET/CT in head and neck cancer – recommendations of an interdisciplinary consensus conference]. Laryngorhinootologie 2009;88:84–90.
  • Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261–9.
  • Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35.
  • Pellitteri PK, Ferlito A, Rinaldo A, Shah JP, Weber RS, Lowry J, et al. Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: is it necessary for all? Head Neck 2006;28:166–75.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.